Detalles de la búsqueda
1.
An open-label, pharmacokinetic study of lenalidomide and dexamethasone therapy in previously untreated multiple myeloma (MM) patients with various degrees of renal impairment - validation of official dosing guidelines.
Leuk Lymphoma
; 61(8): 1860-1868, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32476520
2.
A phase 2 study of ofatumumab (Arzerra®) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL).
Leuk Lymphoma
; 60(1): 92-100, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29916761
3.
A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL).
Leuk Lymphoma
; 60(4): 980-989, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30277089
Resultados
1 -
3
de 3
1
Próxima >
>>